Newsmeme!
Discover News you didn't know existed
Thrombocytopenia
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
Excelsior Medical receives Canadian marketing license for new, pre-filled catheter lock syringe
Published February 9, 2010, 9:56 pm, News-Medical-Net
Excelsior Medical Corporation, one of the leading manufacturers of pre-filled catheter flush syringes, today announced that it has received a Medical Device License from Health Canada for its new, pre-filled catheter lock syringe to be sold in the Canadian marketplace.
Rigel to Present at BIO CEO & Investor Conference
Published February 5, 2010, 9:08 am, redOrbit
SOUTH SAN FRANCISCO, Calif., Feb. 5 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M.
Rigel to Present at BIO CEO & Investor Conference
Published February 5, 2010, 4:30 am, PR Newswire via Yahoo! Finance
Rigel Pharmaceuticals, Inc. today announced that James M. Gower, the company's chairman and chief executive officer, is scheduled to present a company overview at the 12th Annual BIO CEO & Investor Conference in New York City on Monday, February 8th at 10:00 a.m.
NHLBI awarded four contracts to test new devices to help children with congenital heart defects
Published February 4, 2010, 11:16 pm, News-Medical-Net
The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, has awarded four contracts totaling $23.6 million to begin preclinical testing of devices to help children born with congenital heart defects or those who develop heart failure.
Press Release
Published February 4, 2010, 9:40 am, PharmiWeb
Shire Submits Biologics License Application (BLA) for REPLAGAL(R) With the U.S. Food and Drug Administration (FDA)- Filing Underscores Shire's Ongoing Commitment to Providing U.S. Fabry Patients With an Alternative Treatment Option.
Poniard laying off staff, changing leadership
Published February 3, 2010, 11:34 am, KIFI Idaho Falls
Poniard Pharmaceuticals said Wednesday it will lay off more than half its work force and replace CEO Jerry McMahon.
Poniard laying off staff, changing leadership
Published February 3, 2010, 11:09 am, San Francisco Chronicle
Poniard Pharmaceuticals said Wednesday it will lay off more than half its work force and replace CEO Jerry McMahon. The company said it will cut staff by 57 percent, leaving 21 workers in an effort to cut costs and focus on its potential cancer drug... Cancer - Drug - Business - Pharmaceuticals - Biotechnology and Pharmaceuticals
Poniard laying off staff, changing leadership
Published February 3, 2010, 10:42 am, INO News
(AP:SOUTH SAN FRANCISCO, Calif.) Poniard Pharmaceuticals said Wednesday it will lay off more than half its work force and replace CEO Jerry McMahon. The company said it will cut staff by 57 percent, leaving 21 workers in an effort to cut costs and focus on its potential cancer drug picoplatin.
Poniard Laying off Staff, Changing Leadership
Published February 3, 2010, 10:40 am, ABC News
Poniard Pharmaceuticals laying off more than half its staff, changing leadership Business - Management - Leadership - Pharmaceuticals - Biotechnology and Pharmaceuticals
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |